Victor Golmer/iStock Editorial via Getty Images Grifols ( NASDAQ: GRFS ) rose 4% after a report that Brookfield Asset Management ( BAM ) is still evaluating a takeover of the Spanish drugmaker and is confident it has the funding for a deal. Brookfield ( BAM ) is awaiting information from Grifols ( GRFS.
Back to Health Page
